Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Haffty

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Cancer Research|March 8, 2000
Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancerT A Lehman, B G Haffty, C J Carbone, et al.
Cancer Research|December 16, 1998
Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathwaysB C Turner, J Zhang, A A Gumbs, et al.
Radiation Oncology Investigations|January 1, 1997
Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neckB G Haffty, Y H Son, L D Wilson, et al.
The Cancer Journal From Scientific American|August 10, 1999
Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community settingB Burtness, S Windsor, B Holston, et al.
Cancer Research|August 1, 1997
Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiationB C Turner, B G Haffty, L Narayanan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Postmastectomy radiotherapy: questions for the twenty-first centuryA Recht, H Bartelink, A Fourquet, et al.
Annals of Surgical Oncology|February 25, 2014
Basal subtype, as approximated by triple-negative phenotype, is associated with locoregional recurrence in a case-control study of women with 0-3 positive lymph nodes after mastectomyA J Khan, S A Milgrom, N Barnard, et al.
Cancer|October 1, 1991
Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinomaA H Frank, P C Tseng, B G Haffty, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2021
A Statewide Multi-institutional Study of Asymptomatic Pre-Treatment Testing of Radiation Therapy Patients for SARS-CoV-2 in a High-Incidence Region of the United StatesA E Dragun, C Modi, C F Henson, et al.
Radiology|October 19, 2000
Ductal carcinoma in situ and microinvasive disease. American College of Radiology. ACR Appropriateness CriteriaR A Rabinovitch, L J Solin, B M Shank, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Cancer Research|March 8, 2000
Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancerT A Lehman, B G Haffty, C J Carbone, et al.
Cancer Research|December 16, 1998
Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathwaysB C Turner, J Zhang, A A Gumbs, et al.
Radiation Oncology Investigations|January 1, 1997
Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neckB G Haffty, Y H Son, L D Wilson, et al.
The Cancer Journal From Scientific American|August 10, 1999
Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community settingB Burtness, S Windsor, B Holston, et al.
Cancer Research|August 1, 1997
Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiationB C Turner, B G Haffty, L Narayanan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Postmastectomy radiotherapy: questions for the twenty-first centuryA Recht, H Bartelink, A Fourquet, et al.
Annals of Surgical Oncology|February 25, 2014
Basal subtype, as approximated by triple-negative phenotype, is associated with locoregional recurrence in a case-control study of women with 0-3 positive lymph nodes after mastectomyA J Khan, S A Milgrom, N Barnard, et al.
Cancer|October 1, 1991
Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinomaA H Frank, P C Tseng, B G Haffty, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2021
A Statewide Multi-institutional Study of Asymptomatic Pre-Treatment Testing of Radiation Therapy Patients for SARS-CoV-2 in a High-Incidence Region of the United StatesA E Dragun, C Modi, C F Henson, et al.
Radiology|October 19, 2000
Ductal carcinoma in situ and microinvasive disease. American College of Radiology. ACR Appropriateness CriteriaR A Rabinovitch, L J Solin, B M Shank, et al.
Pageof 10